Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Novartis |
Recipient: You |
Company: Merck |
Recipient: You |
Company: Replimmune |
Recipient: You |
Company: Pfizer |
Recipient: You |
Company: Bristol-Myers Squibb |
Recipient: You |
Company: maren |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Amgen |
Recipient: Your Institution |
Company: Lilly |
Recipient: Your Institution |
Company: BioMed Valley Discoveries |
Recipient: Your Institution |
Company: Merck |
Recipient: Your Institution |
Company: Deciphera |
Recipient: Your Institution |
Company: Roche/Genentech |
Recipient: Your Institution |
Company: Moderna Therapeutics |
Recipient: Your Institution |
Company: Sanofi |
Recipient: Your Institution |
Company: Aeglea Biotherapeutics |
Recipient: Your Institution |
Company: Asana Biosciences |
Recipient: Your Institution |
Company: Viralytics |
Recipient: Your Institution |
Company: Compugen |
Recipient: Your Institution |
Company: Neon Therapeutics |
Recipient: Your Institution |
Company: Pfizer |
Recipient: Your Institution |
Company: BeiGene |
Recipient: Your Institution |
Company: Rubius Therapeutics |
Recipient: Your Institution |
Company: Strategia |
Recipient: Your Institution |
Company: Strategia |
Recipient: Your Institution |
Company: marengo |
Recipient: Your Institution |
Company: Synthekine |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|